Canadian Pharma, Biotech and Life Sciences Stocks

Commodity Volatility 2018-05-18 Video

I posted an additional article regarding this weeks video. This is a link specific to the video. The US Dollar is working real hard against the commodity up trend, but some of the commodities cannot be suppressed. Oil, Natural Gas, Heating Oil, Gasoline, and KOL are all soaring.  I mentioned a ...

The Hydropothecary Corporation is a buy, says Echelon Wealth

Gatineau, Quebec’s The Hydropothecary Corporation (TSXV:THCX) gets a 12-month target price increase from Echelon Wealth Partners’ Russell Stanley, who sees the licensed cannabis producer to be trading at a discount to its peer group of cannabis companies. On Thursday, the analyst’s research ...

Q1 2018 Share Price Performance

Analysis: Healthcare Outperforms the Market Starting this quarter, the Bloom Burton equity research team has taken over responsibility for the “Share Price Performance for the Canadian Healthcare Sector” blog from Wayne Schnarr. With the blog, Wayne created an essential light-reading but infor ...

Aphria has a 115 per cent upside, says PI Financial

Cannabis licensed producer Aphria (TSX:APH) has a couple of new announcements that have helped solidify its distributions in Canada and in Germany, says Jason Zandberg of PI Financial, who on Thursday reiterated his “Buy” recommendation with a Speculative risk rating and $26.00 target price for ...

Village Farms is trading at a major discount to its cannabis peers, Echelon Wealth says

Greenhouse grower Village Farms International (TSX:VFF) may not be a cannabis space household name like Canopy Growth and Aurora Cannabis, but the BC-based company should be getting more respect based on its proven crop-growing chops, says Russell Stanley of Echelon Wealth Partners. In a research ...

Prometic Life Sciences is just too risky, this fund manager says

Prometic Life Sciences (TSX:PLI) may have seen its share price tumble over the past year, but even at the discounted rate there’s a lot of risk involved in owning it, says James Hodgins, chief investment officer at Curvature Hedge Strategies. Laval, Quebec-based biopharm company Prometic Life Sci ...

MedReleaf is a great pickup for Aurora Cannabis, Brett Wilson says

Brett Wilson on BNN Bloomberg Aurora Cannabis’ (TSX:ACB) newly announced acquisition of licensed cannabis producer MedReleaf Corp (TSX:LEAF) vaults Aurora to top spot on the leaderboard, as companies continue to jockey for position in the lead-up to rec legalization. But the move is about more ...

Legalizing marijuana a much tougher sell in the U.S. than Canada, this observer says

Thomas George Thomas George of investment forum Grizzle says that when it comes to the “green rush” of success that the marijuana industry is expecting in Canada, interested parties should be a little more circumspect about getting the same reception south of the border. In fact, the U.S. is f ...

Canopy Growth Corp. is still Canada’s cannabis king, this portfolio manager says

Bruce Campbell With a scant couple of months to go before rec marijuana becomes a legal reality, Canada’s pot co’s are still jockeying for position in the yet-to-be-realized industry, as mergers and acquisitions big and small continue to play out. One of the most interesting issues remaining u ...

Aurora Cannabis should soon pass Canopy Growth Corp. in medical pot sales, PI says

Following the company’s third quarter results, PI Financial analyst Jason Zandberg is feeling bullish about Aurora Cannabis (TSX:ACB). On May 8, ACB posted its Q3, 2018 results. The company lost $20.79-million on revenue of $16.1-million, a topline that was up 211 per cent over last year’s thi ...